Ulcomedina en es it fr

Ulcomedina Brand names, Ulcomedina Analogs

Ulcomedina Brand Names Mixture

  • No information avaliable

Ulcomedina Chemical_Formula


Ulcomedina RX_link


Ulcomedina fda sheet

Ulcomedina FDA

Ulcomedina msds (material safety sheet)

Ulcomedina Synthesis Reference

G. J. Durant et al.; U.S. Pat. 3,950,333 (1976)

Ulcomedina Molecular Weight

252.34 g/mol

Ulcomedina Melting Point

142 oC

Ulcomedina H2O Solubility

0.5 g/100 mL

Ulcomedina State


Ulcomedina LogP


Ulcomedina Dosage Forms

Tablets; Oral solution

Ulcomedina Indication

For the treatment and the management of acid-reflux disorders (GERD), peptic ulcer disease, heartburn, and acid indigestion

Ulcomedina Pharmacology

Cimetidine is a histamine H2-receptor antagonist. It reduces basal and nocturnal gastric acid secretion and a reduction in gastric volume, acidity, and amount of gastric acid released in response to stimuli including food, caffeine, insulin, betazole, or pentagastrin. It is used to treat gastrointestinal disorders such as gastric or duodenal ulcer, gastroesophageal reflux disease, and pathological hypersecretory conditions. Cimetidine inhibits many of the isoenzymes of the hepatic CYP450 enzyme system. Other actions of Cimetidine include an increase in gastric bacterial flora such as nitrate-reducing organisms.

Ulcomedina Absorption

Rapid 60-70%

Ulcomedina side effects and Toxicity

nausea, vomiting, diarrhea, increased saliva production, difficulty breathing, and a fast heartbeat.

Ulcomedina Patient Information

Ulcomedina Organisms Affected

Humans and other mammals